GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma
- DOI
- 10.1016/j.ymthe.2023.11.012
- Published
- 2024-01
- Container
- Molecular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymthe.2023.11.012,
title = {GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma},
author = {Christoph Neumayer and Denise Ng and David Requena and Caroline S. Jiang and Adam Qureshi and Roger Vaughan and Thazha P. Prakash and Alexey Revenko and Sanford M. Simon},
year = {2024},
journal = {Molecular Therapy},
doi = {10.1016/j.ymthe.2023.11.012},
url = {https://doi.org/10.1016/j.ymthe.2023.11.012}
}RIS
TY - JOUR TI - GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma AU - Christoph Neumayer AU - Denise Ng AU - David Requena AU - Caroline S. Jiang AU - Adam Qureshi AU - Roger Vaughan AU - Thazha P. Prakash AU - Alexey Revenko AU - Sanford M. Simon PY - 2024 JO - Molecular Therapy DO - 10.1016/j.ymthe.2023.11.012 UR - https://doi.org/10.1016/j.ymthe.2023.11.012 ER -
APA
Neumayer, C., Ng, D., Requena, D., Jiang, C. S., Qureshi, A., Vaughan, R., Prakash, T. P., Revenko, A., & Simon, S. M. (2024). GalNAc-conjugated siRNA targeting the DNAJB1-PRKACA fusion junction in fibrolamellar hepatocellular carcinoma. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.11.012
Source records
- crossref · retrieved 2026-09-26T08:13:01.926Z